Liftstream is an executive search recruitment company in the life sciences sector

Mereo BioPharma forms with Novartis assets and Institutional Investment

Posted on July 29, 2015 by admin

A new UK company focused on acquiring, rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health

Read the full article…

Posted in M&A Finance and Funding | Tagged Brittle Bone Syndrome, COPD, Denise- Scots-Knihgt, hypogonadotrophic hypogonadism, London Biotech, Mereo BioPharma, Novartis, Orphan Diseases, Peter Fellner, Phase4 Partners, UK, women on boards, Woodford Investment Management | Leave a comment

Novartis scores FDA breakthrough-designation for rare disease product

Posted on August 30, 2013 by admin

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases | Tagged American Neurological Association, antibody, bimagrumab, Breakthrough Therapy, BYM338, cancer, celgene, COPD, FDA, HuCAL, mAb, MOR202, Morphosys, muscle wasting, Novartis, Orphan Drug, Rare Disease, sIBM | Leave a comment

Knowledge at the heart of leadership

Liftstream is an executive search recruitment company in the life sciences sector

Mereo BioPharma forms with Novartis assets and Institutional Investment

Novartis scores FDA breakthrough-designation for rare disease product

Sign up for our mailing list.

Navigate

Archives

Recent Posts

Categories

Contact Us

Register your CV

Follow Us

Legal Statements

Knowledge at the heart of leadership

Liftstream is an executive search recruitment company in the life sciences sector

Mereo BioPharma forms with Novartis assets and Institutional Investment

Novartis scores FDA breakthrough-designation for rare disease product

Sign up for our mailing list.

Navigate

Archives

Recent Posts

Categories

Tags

Contact Us

Register your CV

Follow Us

Legal Statements